NCL  
Nanotechnology Characterization Laboratory Skip Navigation
 

Scientific Bibliography

A Scientific Bibliography with topics and abstracts related to nanotechnology is featured on the NCI Alliance for Nanotechnology in Cancer website.

Select NCL publications are listed here:

Evaluation of nanoparticle immunotoxicity [e-pub ahead of print].
Dobrovolskaia MA, Germolec DR, Weaver JL. Nat Nano. 2009 Jun 28; advanced online publication.
View Abstract

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Adv. Drug Deliv. Rev. 2009 Jun 21;61(6):428-437.
View Abstract

Nanoparticle therapeutics: a personal perspective.
McNeil SE.
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2009 ;1(3):264-271.
View Abstract

Role for nanomaterial-autophagy interaction in neurodegenerative disease.
Stern ST and Johnson DN.
Autophagy. 2008 Nov 16; 4(8): 1097-100. PMID: 18927490
View Abstract

Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.
Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, Neun BW, Hall JB, McNeil SE.
Nanomedicine. 2009 Jun; 5(2):106-117. PMID: 19071065
View Abstract

HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents.
Puri A, Kramer-Marek G, Campbell-Massa R, Yavlovich A, Tele SC, Lee SB, Clogston JD, Patri AK, Blumenthal R, Capala J.
Journal of Liposome Research. 2008;18(4):293-307. PMID: 18937120
View Abstract

Adverse effects of fullerenes on endothelial cells: fullerenol C60(OH)24 induced tissue factor and ICAM-I membrane expression and apoptosis in vitro.
Gelderman MP, Simakova O, Clogston JD, Patri AK, Siddiqui SF, Vostal AC, Simak J.
International Journal of Nanomedicine. 2008;3(1):59-68. PMID: 18488416
View Abstract

Detoxification of gold nanorods by treatment with polystyrenesulfonate.
Alexei P. Leonov, Jiwen Zheng, Jeffrey D. Clogston, Stephan T. Stern, Anil K. Patri, and Alexander Wei (2008).
ACS Nano. 2:2481-2488. PMID: 19206282
View Abstract

Induction of autophagy in porcine kidney cells by quantum dots: A common cellular response to nanomaterials?
Stern ST, Zolnik BS, McLeland CB, Clogston J, Zheng J, and McNeil SE
Tox Sci. Web Published on July 15, 2008
View Abstract

Method for analysis of nanoparticle hemolytic properties in vitro.
Dobrovolskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, and McNeil SE
Nano Lett. Web Published on July 8, 2008
View Abstract

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.
Dobrovolskaia MA, Aggarwal P, Hall JB, and McNeil SE
Molecular Pharmaceutics. Web Published on May 29, 2008
View Abstract

Rapid distribution of liposomal short-chain ceramide in vitro and in vivo.
Zolnik BS, Stern ST, Kaiser JM, Heakal Y, Clogston JD, Kester M, and McNeil SE
Drug Metab. Dispos. Web Published on May 19, 2008
View Abstract

Nanotechnology safety concerns revisited.
Stern ST and McNeil SE
Tox Sci. 2008 Jan; 101 (1):4–21
View Abstract

Immunological properties of engineered nanomaterials.
Dobrovolskaia MA and McNeil SE
Nature Nanotechnology. 2007 July; (2):469 - 478
View Abstract

Characterization of nanoparticles for therapeutics.
Hall JB, Dobrovolskaia MA, Patri AK, and McNeil SE
Nanomedicine. 2007 Dec; 2 (6):789-803
View Abstract

Medical opportunities of nanotechnology.
McNeil SE
Iso Focus. 2007 April; Nanotechnologies issue: 16-18
View Abstract

Analysis of fullerene-based nanomaterial in serum matrix by CE.
Chan KC, Patri AK, Veenstra TD, McNeil SE, and Issaq HJ
Electrophoresis. 2007 April; (28):1518–1524
View Abstract

Nanocrystal-based biomimetic system for quantitative flow cytometry.
Yim P, Dobrovolskaia AM, Kang H, Clarke M, Patri AK, and Hwang J
Proceedings of SPIE. 2007 (6430):64301T-9
View Abstract

Preclinical characterization of engineered nanoparticles intended for cancer therapeutics.
Patri AK, Dobrovolskaia MA, Stern ST, and McNeil SE
Nanotechnology for Cancer Therapy. 2006, M. Amiji (ed.)
View Abstract

Nanotechnology for the biologist.
McNeil SE
Journal of Leukocyte Biology. 2005 Sep; 78(3):585-94
View Abstract

 

 
       
       
National Cancer InstituteDepartment of Health and Human ServicesNational Institutes of HealthFirstGov.govNCI - Alliance for Nanotechnology in Cancer
National Cancer Institute U.S. National Institutes of Health www.cancer.gov Nanotechnology Characterization Lab